Menu

Price Performance Heatmap

5Y Price (Market Cap Weighted)

All Stocks (17)

Company Market Cap Price
JNJ Johnson & Johnson
ACUVUE contact lenses and TECNIS intraocular lenses place J&J in ophthalmology devices and eye-care products.
$454.86B
$188.88
-0.09%
ALC Alcon Inc.
Alcon directly designs and manufactures ophthalmology devices including intraocular lenses and surgical platforms.
$36.55B
$73.92
-0.46%
COO The Cooper Companies, Inc.
CooperVision and CooperSurgical primarily manufacture ophthalmology devices and related vision-care products, fitting Ophthalmology Devices.
$13.95B
$69.92
-0.27%
BLCO Bausch + Lomb Corporation
Ophthalmology Devices – direct manufacture and sale of eye-care surgical devices and related ophthalmic equipment.
$5.29B
$14.94
-1.32%
GKOS Glaukos Corporation
Glaukos directly manufactures ophthalmology devices, including iStent MIGS implants used in eye surgeries.
$5.03B
$88.05
+0.28%
BHC Bausch Health Companies Inc.
Bausch Health’s Bausch + Lomb segment includes ophthalmology devices such as intraocular lenses (IOLs).
$2.60B
$7.03
+6.28%
OCUL Ocular Therapeutix, Inc.
DEXTENZA and other retina products are ophthalmology devices sold by the company.
$1.86B
$11.65
-1.40%
STAA STAAR Surgical Company
STAAR directly manufactures ophthalmic medical devices, primarily implantable lenses (EVO ICL) used for vision correction.
$1.28B
$25.87
-2.49%
INMD InMode Ltd.
Envision is an ophthalmology-focused platform, representing a direct ophthalmology devices product line.
$1.14B
$14.77
+0.37%
EYPT EyePoint Pharmaceuticals, Inc.
Implantable ophthalmic device component due to bioerodible Durasert E delivery system.
$900.75M
$13.11
+7.37%
RXST RxSight, Inc.
RxSight's core offering is the Light Adjustable Lens system and related ophthalmic devices used in premium cataract surgery, which fits Ophthalmology Devices.
$357.20M
$8.79
+2.27%
SGHT Sight Sciences, Inc.
Directly manufactures ophthalmic surgical devices (OMNI Surgical System, TearCare-related tools) used in eye care, i.e., ophthalmology devices.
$261.61M
$5.07
-0.30%
LNSR LENSAR, Inc.
Direct ophthalmic device product (Ophthalmology Devices) produced by LENSAR via the ALLY robotic cataract laser system.
$145.04M
$12.32
+2.24%
ABVC ABVC BioPharma, Inc.
Vitargus is a vitreous substitute device, aligning with ophthalmology devices.
$46.97M
$2.77
-1.77%
POCI Precision Optics Corporation, Inc.
The company produces ophthalmic endoscopes and related ophthalmology imaging devices, fitting Ophthalmology Devices.
$32.96M
$4.30
CLSD Clearside Biomedical, Inc.
SCS Microinjector is a medical device used for ophthalmology applications (back-of-eye injections).
$21.08M
$4.03
+6.90%
IRIX IRIDEX Corporation
IRIDEX directly designs, manufactures and sells ophthalmology devices (laser platforms, delivery systems) for eye diseases.
$17.63M
$1.04
-1.42%

Loading company comparison...

Loading research report...

ALC Alcon Inc.

Yunqi Capital Urges STAAR Surgical Board to Terminate Alcon Merger

Oct 31, 2025
ALC Alcon Inc.

STAAR Surgical Postpones Special Meeting of Stockholders to December 3, 2025, Extending Merger Timeline with Alcon

Oct 27, 2025
STAA STAAR Surgical Company

STAAR Surgical Postpones Shareholder Meeting on Alcon Merger to December 3, 2025

Oct 27, 2025
ALC Alcon Inc.

Broadwood Partners Condemns Alcon‑STAAR Decision to Delay Final Merger Vote

Oct 24, 2025
STAA STAAR Surgical Company

Broadwood Partners Plans Special Meeting to Remove STAAR Surgical Directors Amid Alcon Deal

Oct 24, 2025
SGHT Sight Sciences, Inc.

Sight Sciences Secures Medicare Fee Schedule for TearCare Procedure

Oct 17, 2025
GKOS Glaukos Corporation

Glaukos Breaks Ground on New R&D and Manufacturing Facility in Huntsville, Alabama

Sep 25, 2025
COO The Cooper Companies, Inc.

CooperCompanies Expands Share Repurchase Program to $2 Billion

Sep 17, 2025
IRIX IRIDEX Corporation

Iridex Corporation Regains Nasdaq Listing Compliance

Sep 09, 2025
GKOS Glaukos Corporation

Glaukos Extends NCX 1728 Research Agreement with Nicox

Sep 04, 2025
COO The Cooper Companies, Inc.

CooperCompanies Reports Fiscal Q3 2025 Results, Raises EPS Guidance Despite Revenue Miss

Aug 27, 2025
COO The Cooper Companies, Inc.

CooperVision Canada Continues Myopia Awareness Campaign for Fifth Year

Aug 18, 2025
IRIX IRIDEX Corporation

Iridex Reports Q2 2025 Financial Results, Achieves Third Consecutive Quarter of Positive Adjusted EBITDA

Aug 12, 2025
GKOS Glaukos Corporation

Glaukos Reports Record Second Quarter 2025 Financial Results, Raises Full-Year Net Sales Guidance

Jul 30, 2025
GKOS Glaukos Corporation

Glaukos Corporation Added to Russell 2000 Defensive Index

Jun 30, 2025
GKOS Glaukos Corporation

Glaukos Receives EU MDR Certification for iStent infinite® and Other MIGS Therapies

Jun 25, 2025
IRIX IRIDEX Corporation

Iridex Announces First Patient Enrolled in UK DAME Trial for Diabetic Macular Edema

Jun 24, 2025
GKOS Glaukos Corporation

Glaukos Files 2024 Form SD and Conflict Minerals Report

Jun 01, 2025
COO The Cooper Companies, Inc.

CooperCompanies Reports Solid Fiscal Q2 2025 Results, Raises EPS Guidance Despite Market Softness

May 29, 2025
COO The Cooper Companies, Inc.

CooperCompanies Releases 2024 Sustainability Report, Highlighting ESG Initiatives

May 20, 2025
IRIX IRIDEX Corporation

Iridex Reports Q1 2025 Financial Results, Achieves Second Consecutive Quarter of Positive Adjusted EBITDA

May 13, 2025
COO The Cooper Companies, Inc.

CooperCompanies Appoints Barbara Carbone to Board of Directors

Apr 30, 2025
GKOS Glaukos Corporation

Glaukos Reports Record First Quarter 2025 Financial Results, Reaffirms Full-Year Guidance

Apr 30, 2025
GKOS Glaukos Corporation

Glaukos Presents Scientific Abstracts at 2025 American Society of Cataract and Refractive Surgery Annual Meeting

Apr 25, 2025
COO The Cooper Companies, Inc.

CooperSurgical Joins 2025 IVF Grant Program to Support Fertility Access

Apr 22, 2025
GKOS Glaukos Corporation

Glaukos Releases 2024 Sustainability Report

Apr 14, 2025
IRIX IRIDEX Corporation

Iridex Reports Positive Q4 2024 Adjusted EBITDA, Provides 2025 Financial Outlook

Mar 27, 2025
IRIX IRIDEX Corporation

Iridex Secures $10 Million Strategic Investment from Novel Inspiration, Appoints New CFO

Mar 19, 2025
GKOS Glaukos Corporation

Glaukos Collaborates with RadiusXR and Topcon Healthcare to Launch Inspire® Visual Field Solution

Mar 11, 2025
COO The Cooper Companies, Inc.

CooperCompanies Announces Fiscal First Quarter 2025 Results, Updates Full-Year Guidance

Mar 06, 2025
GKOS Glaukos Corporation

FDA Accepts Glaukos' NDA for Epioxa™, Sets October 20, 2025 PDUFA Date

Feb 24, 2025
GKOS Glaukos Corporation

Glaukos Reports Record Fourth Quarter and Full Year 2024 Financial Results, Issues 2025 Guidance

Feb 20, 2025
GKOS Glaukos Corporation

Glaukos Outlines Strategic Vision and 2025-26 Commercial Catalysts at J.P. Morgan Healthcare Conference

Jan 14, 2025
GKOS Glaukos Corporation

Glaukos Submits New Drug Application to U.S. FDA for Epioxa™

Dec 23, 2024
IRIX IRIDEX Corporation

Five-Year Study Confirms Long-Term Effectiveness and Safety of Iridex MicroPulse TLT for Glaucoma

Dec 18, 2024
COO The Cooper Companies, Inc.

CooperCompanies Reports Strong Fiscal Q4 and Full Year 2024 Results, Initiates Fiscal 2025 Guidance

Dec 05, 2024
IRIX IRIDEX Corporation

Iridex Glaucoma Treatments Unaffected by New Medicare Reimbursement Limitations

Nov 19, 2024
GKOS Glaukos Corporation

Glaukos Highlights Strong iDose TR Clinical Data and Strategic Investments in Investor Presentation

Nov 15, 2024
IRIX IRIDEX Corporation

Iridex Reports Q3 2024 Financial Results, Targets Q4 EBITDA Breakeven

Nov 12, 2024
GKOS Glaukos Corporation

Glaukos Reports Strong Third Quarter 2024 Results, Raises Full-Year Net Sales Guidance

Nov 04, 2024
GKOS Glaukos Corporation

Glaukos Showcases Technologies at 2024 American Academy of Ophthalmology Annual Meeting

Oct 18, 2024
GKOS Glaukos Corporation

Glaukos Enters Licensing Agreement with Ripple Therapeutics for Sustained-Release Therapies

Oct 16, 2024

The most compelling investment themes are the ones nobody is talking about yet.

Every Monday, get three under-the-radar themes with catalysts, data, and stocks poised to benefit.

Sign up now to receive them!

Also explore our analysis on 5,000+ stocks